Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Refer MSDS for complete information
Synonyms
9-ethyl-6,11-dihydro-6,6-di(methyl-d3)-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-Benzo[b]carbazole-3-carbonitrile; Alectinib-d6
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Alectinib-d6 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Alectinib-d6 usage and description
Alectinib D6 is a deuterated form of Alectinib, a drug used in the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Alectinib D6 is a tyrosine kinase inhibitor that works by blocking the action of anaplastic lymphoma kinase (ALK), a protein that promotes the growth and spread of cancer cells. By inhibiting ALK, Alectinib D6 helps to slow down or stop the growth of cancer cells, thereby improving the patient's chances of survival.
In terms of its chemical properties, Alectinib D6 is a white to off-white powder with a molecular weight of 555.67 g/mol. It is slightly soluble in water and has a melting point of 184-187°C. Alectinib D6 is also known by its chemical name, (R)-1-(2,6-dichloro-3-fluorophenyl)-2-[(1-methylpiperidin-4-yl)amino]-1-(4-(4-deuterium-labeled-phenyl)piperidin-4-yl)ethanol.
Alectinib D6 is typically administered orally in capsule form, and the dosage and duration of treatment may vary depending on the patient's age, weight, and overall health status. Common side effects of Alectinib D6 include fatigue, nausea, diarrhea, and muscle pain. Patients taking this medication should also be monitored for potential liver and kidney problems, as well as any signs of allergic reactions or other serious adverse effects. Overall, Alectinib D6 is an important drug in the fight against NSCLC, and its deuterated form may offer enhanced therapeutic benefits compared to the non-deuterated version.
